Opinion|Videos|May 22, 2024
Overview of Clinical Trials for New Imaging Options for Kidney Cancer
Author(s)Neal Shore, MD, FACS, Brian M. Shuch, MD
Urologists review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab.
Advertisement
Episodes in this series
Advertisement
Related to this article
Robert J. Motzer, MD, discusses the significance of the belzutifan plus lenvatinib approval, adverse event management with the combination, and the evolving role of HIF-2α inhibition in ccRCC.
The approval is supported by data from the phase 3 LITESPARK-011 trial.
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
2
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
3
FDA updates in urology: September 2026
4
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
5